While shortages have been reduced, supply-chain risks from global conflict may reinforce those calling for greater EU autonomy when it comes to medicine supply. The MEPs...
A European Fair Pricing Network study reveals that lower-income countries are paying more for their medicines. A study, entitled “Price transparency of cancer medicines: a crucial...
When Europe’s medicines supply chain comes under strain, community pharmacists are often the first to feel the impact. At a Pharmaceutical Group of the European Union...
The kick-off trilogue on the Critical Medicines Act (CMA) took place on Monday evening (2 February), with discussions described as constructive. Co-legislators reiterated both their readiness...
The European Parliament gave a resounding endorsement of Tomislav Sokol’s (EPP, Croatia) report on the Critical Medicines Act (CMA), setting out the Parliament’s battle lines for...
The European Parliament’s public health committee has endorsed compromise amendments to the Critical Medicines Act, setting out a more ambitious approach than member states. This evening...
EU ministers backed a joint negotiating position on the Critical Medicines Act agreement, but some consider it a missed opportunity.This afternoon (2 December), the Council agreed...
